304 related articles for article (PubMed ID: 12915598)
1. Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia.
Kishi S; Griener J; Cheng C; Das S; Cook EH; Pei D; Hudson M; Rubnitz J; Sandlund JT; Pui CH; Relling MV
J Clin Oncol; 2003 Aug; 21(16):3084-91. PubMed ID: 12915598
[TBL] [Abstract][Full Text] [Related]
2. Effect of methylenetetrahydrofolate reductase 677C-->T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients.
Toffoli G; Russo A; Innocenti F; Corona G; Tumolo S; Sartor F; Mini E; Boiocchi M
Int J Cancer; 2003 Jan; 103(3):294-9. PubMed ID: 12471611
[TBL] [Abstract][Full Text] [Related]
3. Plasma homocysteine in children with acute lymphoblastic leukemia: changes during a chemotherapeutic regimen including methotrexate.
Refsum H; Wesenberg F; Ueland PM
Cancer Res; 1991 Feb; 51(3):828-35. PubMed ID: 1988122
[TBL] [Abstract][Full Text] [Related]
4. Influence of methylene tetrahydrofolate reductase polymorphisms and coadministration of antimetabolites on toxicity after high dose methotrexate.
van Kooten Niekerk PB; Schmiegelow K; Schroeder H
Eur J Haematol; 2008 Nov; 81(5):391-8. PubMed ID: 18691257
[TBL] [Abstract][Full Text] [Related]
5. High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C-->T genotypes.
Lin PT; Huang MC; Lee BJ; Cheng CH; Tsai TP; Huang YC
Asia Pac J Clin Nutr; 2008; 17(2):330-8. PubMed ID: 18586656
[TBL] [Abstract][Full Text] [Related]
6. A polymorphism (80G->A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia.
Chango A; Emery-Fillon N; de Courcy GP; Lambert D; Pfister M; Rosenblatt DS; Nicolas JP
Mol Genet Metab; 2000 Aug; 70(4):310-5. PubMed ID: 10993718
[TBL] [Abstract][Full Text] [Related]
7. Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion.
Di Crecchio L; Parodi MB; Sanguinetti G; Iacono P; Ravalico G
Ophthalmology; 2004 May; 111(5):940-5. PubMed ID: 15121372
[TBL] [Abstract][Full Text] [Related]
8. Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis.
Schmeling H; Biber D; Heins S; Horneff G
J Rheumatol; 2005 Sep; 32(9):1832-6. PubMed ID: 16142884
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes.
Wessels JA; de Vries-Bouwstra JK; Heijmans BT; Slagboom PE; Goekoop-Ruiterman YP; Allaart CF; Kerstens PJ; van Zeben D; Breedveld FC; Dijkmans BA; Huizinga TW; Guchelaar HJ
Arthritis Rheum; 2006 Apr; 54(4):1087-95. PubMed ID: 16572443
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of methylenetetrahydrofolate reductase modifies response to methotrexate in mice.
Celtikci B; Leclerc D; Lawrance AK; Deng L; Friedman HC; Krupenko NI; Krupenko SA; Melnyk S; James SJ; Peterson AC; Rozen R
Pharmacogenet Genomics; 2008 Jul; 18(7):577-89. PubMed ID: 18551038
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of MTHFR 677C-->T missense mutation, total plasma homocysteine levels and associated risk factors in Malay subjects.
Ling KH; Rosli R; Duraisamy G; Nasir MT
Med J Malaysia; 2003 Jun; 58(2):243-54. PubMed ID: 14569745
[TBL] [Abstract][Full Text] [Related]
12. Influence of MTHFR and RFC1 polymorphisms on toxicities during maintenance chemotherapy for childhood acute lymphoblastic leukemia or lymphoma.
Shimasaki N; Mori T; Torii C; Sato R; Shimada H; Tanigawara Y; Kosaki K; Takahashi T
J Pediatr Hematol Oncol; 2008 May; 30(5):347-52. PubMed ID: 18458567
[TBL] [Abstract][Full Text] [Related]
13. Reduced folate carrier mutations are not the mechanism underlying methotrexate resistance in childhood acute lymphoblastic leukemia.
Kaufman Y; Drori S; Cole PD; Kamen BA; Sirota J; Ifergan I; Arush MW; Elhasid R; Sahar D; Kaspers GJ; Jansen G; Matherly LH; Rechavi G; Toren A; Assaraf YG
Cancer; 2004 Feb; 100(4):773-82. PubMed ID: 14770434
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate toxicity and efficacy during the consolidation phase in paediatric acute lymphoblastic leukaemia and MTHFR polymorphisms as pharmacogenetic determinants.
D'Angelo V; Ramaglia M; Iannotta A; Crisci S; Indolfi P; Francese M; Affinita MC; Pecoraro G; Napolitano A; Fusco C; Oreste M; Indolfi C; Casale F
Cancer Chemother Pharmacol; 2011 Nov; 68(5):1339-46. PubMed ID: 21590445
[TBL] [Abstract][Full Text] [Related]
15. [Study on the relationship between methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine level in pregnancy induced hypertension patients].
Li K; Sun Y; Chen L
Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):205-7. PubMed ID: 11776159
[TBL] [Abstract][Full Text] [Related]
16. Influence of combined methylenetetrahydrofolate reductase (MTHFR) and thymidylate synthase enhancer region (TSER) polymorphisms to plasma homocysteine levels in Korean patients with recurrent spontaneous abortion.
Kim NK; Choi YK; Kang MS; Choi DH; Cha SH; An MO; Lee S; Jeung M; Ko JJ; Oh D
Thromb Res; 2006; 117(6):653-8. PubMed ID: 15985285
[TBL] [Abstract][Full Text] [Related]
17. MTHFR 677 (C-->T) polymorphism is not relevant for prognosis or therapy-associated toxicity in pediatric NHL: results from 484 patients of multicenter trial NHL-BFM 95.
Seidemann K; Book M; Zimmermann M; Meyer U; Welte K; Stanulla M; Reiter A
Ann Hematol; 2006 May; 85(5):291-300. PubMed ID: 16463153
[TBL] [Abstract][Full Text] [Related]
18. High dose methotrexate treatment in childhood ALL: pilot study on the impact of the MTHFR 677C>T and 1298A>C polymorphisms on MTX-related toxicity.
Haase R; Elsner K; Merkel N; Stiefel M; Mauz-Körholz C; Kramm CM; Körholz D
Klin Padiatr; 2012 Apr; 224(3):156-9. PubMed ID: 22513795
[TBL] [Abstract][Full Text] [Related]
19. Subacute methotrexate neurotoxicity and cerebral venous sinus thrombosis in a 12-year-old with acute lymphoblastic leukemia and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: homocysteine-mediated methotrexate neurotoxicity via direct endothelial injury.
Mahadeo KM; Dhall G; Panigrahy A; Lastra C; Ettinger LJ
Pediatr Hematol Oncol; 2010 Feb; 27(1):46-52. PubMed ID: 20121554
[TBL] [Abstract][Full Text] [Related]
20. Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia.
Aplenc R; Thompson J; Han P; La M; Zhao H; Lange B; Rebbeck T
Cancer Res; 2005 Mar; 65(6):2482-7. PubMed ID: 15781665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]